The global orthobiologics market is predicted to exceed $5.52 billion in 2019, according to Transparency Market Research.
Here are four highlights:
1. In 2012 the market was worth $3.75 billion, and it grew at a 5.9 percent compound annual growth rate since.
2. North America and Europe dominate the market due to the high instances of arthritis and high obesity rates, creating a demand for bone grafting.
3. The Asia-Pacific region is expected to see the highest growth in 2019 due to the increase in orthopedic diseases caused by lifestyle changes and bone disorders.
4. Key market competitors include Medtronic, DePuy Synthes, Wright Medical, Stryker, Orthofix and NuVasive.